摘要
目的:观察康莱特联合化学药物动脉灌注治疗转移性肝癌的疗效。方法:152例转移性肝癌患者随机分为治疗组(康莱特联合化学药物动脉灌注)79例、对照组(化学药物动脉灌注)73例。结果:治疗组的稳定率为87.3%,1年生存率为73.4%,2年生存率为50.6%,均明显高于对照组;并可减低血液高凝状态,提高患者的细胞免疫功能,缓解化疗药物的毒副反应,改善患者的生活质量。结论:康莱特联合化学药物动脉灌注治疗转移性肝癌有较好的疗效。
Objective: To evaluate the effects of Kanglaite injection combined with chemical medicine through artery infusion on hepatic metastasis carcinoma. Method: 152 cases of hepatic metastasis carcinoma were randomly divided into the experiment group (artery infusion of Kanglaite injection combined with chemical medicine, 79 cases) and the control group (artery infusion of chemical medicine only, 73 cases). Results: The stability rate of the experiment group is 87.3%, one-year living rate of the experiment group is 73.4% and two-year living rate is 50.6%, both of which are remarkably higher than those of the control group. In addition, the experiment group's hypercoagulation of blood is reduced, the toxic effect and side effect of the chemical medicine are also decreasing, and the living quality of the patients is improved. Conclusions: Kanglaite injection combined with chemical medicine through artery infusion has relatively better curative effects on hepatic metastasis carcinoma.
出处
《中国中医药信息杂志》
CAS
CSCD
2003年第11期13-14,共2页
Chinese Journal of Information on Traditional Chinese Medicine
